Anzeige
Mehr »
Sonntag, 19.04.2026 - Börsentäglich über 12.000 News
Deutliche Überlegenheit der Erzgehalte: Die Zahlen lügen nicht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrBruker Launches MyGenius PRO Automated Molecular Diagnostics System in Europe
FrWuXi Biologics Recognized as ESG Leader by Morningstar Sustainalytics
FrRepligen Opens Training & Innovation Center in Breda
DoMabwell Secures Strategic License and Commercialization Agreement for Denosumab Biosimilars in Malaysia
DoHarbour BioMed Appoints Adam Zong, PhD, President
DoBioMed X France Launches First Research Team on Servier's R&D Campus
DoPanthera Biopartners Acquires Hungarian CRO OEC
DoVir Biotechnology Completes Astellas Deal to Advance Prostate Cancer Immunotherapy
DoPiramal, Aji Bio-Pharma Partner to Support ADC Development & Manufacturing
DoHelus Pharma Appoints Dr. Ken Kramer as SVP, Medical Affairs
MiSQ Innovation and FIS Ink Agreement for Long-Term Supply of Pharma-Grade Furosemide
MiWuXi Biologics Garners ISO 13485 Certification for Drug-Device Combination Product Manufacturing
MiCurative Biotech Engages Sterling Pharma for Clinical Supply of Metformin-Based Ophthalmic Treatment
MiFUJIFILM Biotechnologies Opens New Quality Control Lab in Denmark
MiEnveda Names Christopher Porter SVP of Clinical Operations
MiOryon Cell Therapies Appoints Dr. Burkhard Blank as Chief Medical Officer
MiArdena Opens GLP Bioanalytical Lab in Somerset, NJ
MiCircio, Acuitas Partner to Advance In Vivo CAR-T Therapy Using Circular RNA
MiEvotec Names Chief Operating Officer
DiFDA Approves Travere's Filspari for Treatment of Focal Segmental Glomerulosclerosis
DiLabcorp Unites With AWS and Datavant on AI Platform to Accelerate Alzheimer's Research
DiBostonGene, ImmunoGenesis Partner to Accelerate Development of Immune Checkpoint Inhibitor
DiParabilis Medicines Updates Executive Leadership Team
DiVasa Therapeutics to Use Eli Lilly AI Platform in Drug Discovery Collaboration
DiValo Health Taps Dr. Chris Anagnostopoulos as Chief Causal AI Officer